IL-13 elicits a broad spectrum of effector type 2 immune functions including eosinophilic inflammation, mucus secretion, and airway hyperresponsiveness (Rothenberg and Hogan, 2006; Takatsu et al., 2009). Here, IL13 is linked to airway hyperresponsiveness.